Pancreatic Cancer Research

ResearcherBaylor College of MedicineNo recent work listed

Riyaz M. Basha

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4071-0993; OpenAlex author ID A5007695569. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 10

  1. Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1. Co-author DOI 10.1016/j.semcancer.2021.11.003↗
  2. Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cells. Last author DOI 10.1016/j.procbio.2019.10.022↗
  3. Pancreatic Cancer: An Emphasis on Current Perspectives in Immunotherapy. Last author DOI 10.1615/critrevoncog.2019031417↗
  4. Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. Last author DOI 10.1016/j.critrevonc.2018.03.016↗
  5. Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors. Last author DOI 10.1159/000495715↗
  6. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells. Last author DOI 10.18632/oncotarget.14651↗
  7. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disruptin… Co-author DOI 10.1016/j.jnutbio.2016.01.003↗
  8. Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) tra… Co-author DOI 10.1074/jbc.m114.592576↗
  9. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors. Co-author DOI 10.1093/carcin/bgt231↗
  10. Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy. Last author DOI 10.2174/092986712801661077↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Umesh T. Sankpal · 6 shared papers, 2012–2020 · strength 0.44
  2. Ganji Purnachandra Nagaraju · 3 shared papers, 2016–2022 · strength 0.37
  3. Myrna Hurtado · 4 shared papers, 2017–2020 · strength 0.35
  4. Rama Rao Malla · 1 shared paper, 2022 · strength 0.22
  5. Ion G. Motofei · 1 shared paper, 2022 · strength 0.22
  6. Bassel F. El‐Rayes · 2 shared papers, 2016–2018 · strength 0.14
  7. Krishna J. Patel · 1 shared paper, 2019 · strength 0.11
  8. Amalendu Prakash Ranjan · 1 shared paper, 2018 · strength 0.09
  9. Vijayalekshmi Nair · 2 shared papers, 2013–2014 · strength 0.09
  10. Maen Abdelrahim · 2 shared papers, 2013–2014 · strength 0.09
  11. Stephen H Safe · 2 shared papers, 2013–2014 · strength 0.09
  12. Mamoru Shoji · 1 shared paper, 2016 · strength 0.05
  13. Omar Roger Kayaleh · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.